Dermatomyositis Terminated Phase Trials for Apremilast (DB05676)

Also known as: Dermatomyositides / Dermatopolymyositis, unspecified

IndicationStatusPhase
DBCOND0002234 (Dermatomyositis)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01140503A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With DermatomyositisTreatment